I Dybedal, J Lamvik. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » Acute DiseaseAdultCytarabine/adverse effectsCytarabine/therapeutic useFemaleHumansLeukemia/drug therapyLeukemia, Myeloid, Acute/drug therapyMalePrecursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapyRespiratory Insufficiency/chemically inducedSepsis/chemically inducedStreptococcal Infections/etiology
Substances: See more » Cytarabine
Year: 1989 PMID: 2721663
Source DB: PubMed Journal: Eur J Haematol ISSN: 0902-4441 Impact factor: 2.997